Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLC

Schmidt LH, Kuemmel A, Schliemann C, Schulze A, Humberg J, Mohr M, Görlich D, Hartmann W, Bröckling S, Marra A, Hillejan L, Goletz S, Karsten U, Berdel WE, Spieker T, Wiewrodt R (2016)
In: Lung Cancer, 92
Type of Publication: Research article (journal)

PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups

Schmidt Lars Henning, Kümmel Andreas , Görlich Dennis, Mohr Michael, Bröckling Sebastian, Mikesch Jan Henrik, Grünewald Inga, Marra Alessandro, Schultheis Anne M, Wardelmann Eva , Müller-Tidow Carsten, Spieker Tilmann, Schliemann Christoph, Berdel Wolfgang E, Wiewrodt Rainer, Hartmann Wolfgang (2015)
In: PloS one, 10(8)
Type of Publication: Research article (journal)

pp32/PHAPI determines the apoptosis response of non-small-cell lung cancer.

Hoffarth S, Zitzer A, Wiewrodt R, Hähnel PS, Beyer V, Kreft A, Biesterfeld S, Schuler M (2008)
In: Cell Death and Differentiation, 15(1)
Type of Publication: Research article (journal)

The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells.

von Haussen J, Koczulla R, Shaykhiev R, Herr C, Pinkenburg O, Reimer D, Wiewrodt R, Biesterfeld S, Aigner A, Czubayko F, Bals R (2008)
In: Lung Cancer, 59(1)
Type of Publication: Research article (journal)

Publications

Contact

Top-Links

High-Intensity Physical Exercise in a Glioblastoma Patient under Multimodal Treatment Troschel, FM; Brandt R; Wiewrodt R; Stummer W; Wiewrodt D (2019) In: Medicine and Science in Sports and Exercise, Med Sci Sports E(51(12)) Type of Publication: Research article (journal)
Blood group antigen A type 3 expression is a favorable prognostic factor in advanced NSCLC Schmidt LH, Kuemmel A, Schliemann C, Schulze A, Humberg J, Mohr M, Görlich D, Hartmann W, Bröckling S, Marra A, Hillejan L, Goletz S, Karsten U, Berdel WE, Spieker T, Wiewrodt R (2016) In: Lung Cancer, 92 Type of Publication: Research article (journal)
Thoracic malignancies and pulmonary nodules in patients under evaluation for Transcatheter Aortic Valve Implantation (TAVI): Incidence, follow up and possible impact on treatment… Schmidt L., Vietmeier B., Kaleschke G., Schülke C., Görlich D., Schliemann C., Kessler T., Schulze AB., Buerke B., Kuemmel A., Thrull M., Wiewrodt R., Baumgartner H., Berdel W., Mohr M. (2016) In: PloS one, 11(5) Type of Publication: Research article (journal)
PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups Schmidt Lars Henning, Kümmel Andreas , Görlich Dennis, Mohr Michael, Bröckling Sebastian, Mikesch Jan Henrik, Grünewald Inga, Marra Alessandro, Schultheis Anne M, Wardelmann Eva , Müller-Tidow Carsten, Spieker Tilmann, Schliemann Christoph, Berdel Wolfgang E, Wiewrodt Rainer, Hartmann Wolfgang (2015) In: PloS one, 10(8) Type of Publication: Research article (journal)
Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in NSCLC Schmidt LH, Görlich D, Spieker T, Rohde C, Schuler M, Mohr M, Humber J, Sauer T, Thoenissen NH, Huge T, Voss R. Marra A, Faldum A, Müller-Tidow C, Berdel WE, Wiewrodt R (2014) In: Journal of Thoracic Oncology, 9(9) Type of Publication: Research article (journal)
pp32/PHAPI determines the apoptosis response of non-small-cell lung cancer. Hoffarth S, Zitzer A, Wiewrodt R, Hähnel PS, Beyer V, Kreft A, Biesterfeld S, Schuler M (2008) In: Cell Death and Differentiation, 15(1) Type of Publication: Research article (journal)
Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Chapman CJ, Murray A, McElveen JE, Sahin U, Luxemburger U, Türeci O, Wiewrodt R, Barnes AC, Robertson JF (2008) In: Thorax, 63(3) Type of Publication: Research article (journal)
The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells. von Haussen J, Koczulla R, Shaykhiev R, Herr C, Pinkenburg O, Reimer D, Wiewrodt R, Biesterfeld S, Aigner A, Czubayko F, Bals R (2008) In: Lung Cancer, 59(1) Type of Publication: Research article (journal)